FOXO3 and chronic kidney disease: In summary, we identify HDAC4 as a master regulator of the AKI–CKD transition, acting through coordinated deacetylation and phosphorylation of Foxo3a to repress GPX4, exacerbate lipid peroxidation, and drive ferroptosis.